Current Cancer Drug Targets

Ruiwen Zhang 
Texas Tech University Health Sciences Center
1300 Coulter Drive
Amarillo, TX 79106
USA

Back

Editorial (Hot Topic Potential Value and Limitation of Dual Inhibitors of PI3K and mTOR in the Treatment of Cancer) free to download

Volume:13   Issue:2
Pp: 117-120
Jiezhong Chen
DOI: 10.2174/1568009611313020001

Order Reprints Order Eprints

The PI3 Kinase Signaling Pathway in Prostate Cancer

Volume:13   Issue:2
Pp: 157-164
Aymen A. Elfiky and Zhenyang Jiang
DOI: 10.2174/1568009611313020005

Order Reprints Order Eprints

Studies of NVP-BEZ235 in Melanoma

Volume:13   Issue:2
Pp: 165-174
Joshua A. Sznol, Lucia B. Jilaveanu and Harriet M. Kluger
DOI: 10.2174/1568009611313020006

Order Reprints Order Eprints

Current Status and Future Perspectives of PI3K and mTOR Inhibitor as Anticancer Drugs in Breast Cancer open access plus

Volume:13   Issue:2
Pp: 175-187
Xiaobei Zhang, Xi-ru Li and Jin Zhang
DOI: 10.2174/1568009611313020007

Order Reprints Order Eprints

Novel Approaches for Molecular Targeted Therapy of Breast Cancer: Interfering with PI3K/AKT/mTOR Signaling open access plus

Volume:13   Issue:2
Pp: 188-204
Thomas W. Grunt and Gabriella L. Mariani
DOI: 10.2174/1568009611313020008

Order Reprints Order Eprints

Current and Potential Treatments for Cervical Cancer

Volume:13   Issue:2
Pp: 205-220
Grace P.C. Yee, Paul de Souza and Levon M. Khachigian
DOI: 10.2174/1568009611313020009

Order Reprints Order Eprints

The miR-183/96/182 Cluster Regulates Oxidative Apoptosis and Sensitizes Cells to Chemotherapy in Gliomas

Volume:13   Issue:2
Pp: 221-231
Hailin Tang, Yanhui Bian, Chaofeng Tu, Zeyou Wang, Zhibin Yu, Qing Liu, Gang Xu, Minghua Wu and Guiyuan Li
DOI: 10.2174/1568009611313020010

Order Reprints Order Eprints